Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-based Chemotherapy in Non-Small Cell Lung Cancer Patients
British Journal of Clinical Pharmacology, 07/27/2012
Clinical Article
Xu X et al. – eIF3α Arg803Lys was associated with platinum toxicity in non–small cell lung cancer (NSCLC) patients, and could be considered as a predictor for pretreatment evaluation in lung cancer patients.



